Attention-deficit/hyperactivity disorder (ADHD) medications remain associated with a reduced risk for various real-world ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

A major Swedish study of 247,420 individuals with attention-deficit/hyperactivity disorder (ADHD) has found that medication ...

The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit ...

Discover a study that explores how a personalised mHealth exercise program can effectively improve ADHD symptoms in children.

While ADHD medications continue to reduce the risk for self-harm, injury, and car crashes, recent expanded prescribing ...

Medications for attention-deficit/hyperactivity disorder (ADHD) have some side effects that are common, while others are more ...

A nationwide Finnish study shows that children with ADHD stay on medication for over three years on average. Yet, controlled ...

Telehealth prescribing of stimulants for teens and adults with ADHD is not linked to a higher risk for substance use disorder vs in-person prescribing, a new study shows.

Figures suggest adults with ADHD are five times more likely to try to take their own lives than those without it. | ITV News ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...